Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3709504014 | Product containing dexamethasone and tramazoline in nasal dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3709505010 | Dexamethasone- and tramazoline-containing product in nasal dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing dexamethasone and tramazoline in nasal dose form (medicinal product form) | Has active ingredient | Dexamethasone | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing dexamethasone and tramazoline in nasal dose form (medicinal product form) | Has manufactured dose form | Nasal dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing dexamethasone and tramazoline in nasal dose form (medicinal product form) | Is a | Product containing tramazoline in nasal dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing dexamethasone and tramazoline in nasal dose form (medicinal product form) | Is a | Product containing dexamethasone in nasal dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing dexamethasone and tramazoline in nasal dose form (medicinal product form) | Has active ingredient | Tramazoline | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing dexamethasone and tramazoline in nasal dose form (medicinal product form) | Is a | Product containing dexamethasone and tramazoline | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely dexamethasone isonicotinate 20 microgram and tramazoline hydrochloride 120 microgram/1 actuation conventional release nasal spray (clinical drug) | Is a | False | Product containing dexamethasone and tramazoline in nasal dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
| Product containing only dexamethasone and tramazoline in nasal dose form (medicinal product form) | Is a | True | Product containing dexamethasone and tramazoline in nasal dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR